Development of a phase III trial of hematopoietic stem cell transplantation for systemic lupus erythematosus

R. K. Burt*, A. Marmont, R. Arnold, F. Heipe, G. S. Firestein, E. Carrier, B. Hahn, W. Barr, Y. Oyama, J. Snowden, K. Kalunian, A. Traynor

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

At Northwestern University, a phase I/II trial of hematopoietic stem cell transplant (HSCT) for systemic lupus erythematosus (SLE) has shown promising results. A phase III HSCT trial is being developed to confirm efficacy of HSCT vs continuing the currently accepted standard of care, intravenous pulse cyclophosphamide.

Original languageEnglish (US)
Pages (from-to)S49-S51
JournalBone Marrow Transplantation
Volume32
DOIs
StatePublished - Aug 2003

Keywords

  • Hematopoietic stem cell transplantation
  • Lupus

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Fingerprint Dive into the research topics of 'Development of a phase III trial of hematopoietic stem cell transplantation for systemic lupus erythematosus'. Together they form a unique fingerprint.

Cite this